Need for a Cardiogenic Shock Team Collaborative—Promoting a Team‐Based Model of Care to Improve Outcomes and Identify Best Practices

B Senman, JC Jentzer, CF Barnett… - Journal of the …, 2024‏ - ahajournals.org
Cardiogenic shock continues to carry a high mortality rate despite contemporary care, with
no breakthrough therapies shown to improve survival over the past few decades. It is a time …

Contemporary approach to cardiogenic shock care: a state-of-the-art review

A Mehta, I Vavilin, AH Nguyen, WB Batchelor… - Frontiers in …, 2024‏ - frontiersin.org
Cardiogenic shock (CS) is a time-sensitive and hemodynamically complex syndrome with a
broad spectrum of etiologies and clinical presentations. Despite contemporary therapies, CS …

Prognostic Factors Associated with Mortality in Cardiogenic Shock—A Systematic Review and Meta-Analysis

RG Jung, C Stotts, A Gupta, G Prosperi-Porta… - NEJM …, 2024‏ - evidence.nejm.org
Background Cardiogenic shock remains highly associated with early mortality, with mortality
often exceeding 50%. We sought to determine the association between prognostic factors …

Venoarterial extracorporeal membrane oxygenation in immunocompromised patients with cardiogenic shock: a cohort study and propensity-weighted analysis

Q Moyon, F Triboulet, J Reuter, G Lebreton… - Intensive Care …, 2024‏ - Springer
Purpose The outcomes of immunocompromised patients with cardiogenic shock treated with
venoarterial extracorporeal membrane oxygenation (VA-ECMO) are seldom documented …

Cardiogenic shock

E Lüsebrink, L Binzenhöfer, M Adamo, R Lorusso… - The Lancet, 2024‏ - thelancet.com
Cardiogenic shock is a complex syndrome defined by systemic hypoperfusion and
inadequate cardiac output arising from a wide array of underlying causes. Although the …

Microaxial flow pump use and renal outcomes in infarct-related cardiogenic shock: a secondary analysis of the DanGer Shock trial

E Zweck, C Hassager, RP Beske, LO Jensen… - Circulation, 2024‏ - ahajournals.org
BACKGROUND: In DanGer Shock (the Danish–German Cardiogenic Shock trial), use of a
microaxial flow pump (mAFP) in patients with ST-segment–elevation myocardial infarction …

[HTML][HTML] The role of inflammation in the pathogenesis of cardiogenic shock secondary to Acute myocardial infarction: a narrative review

I Kologrivova, M Kercheva, O Panteleev, V Ryabov - Biomedicines, 2024‏ - mdpi.com
Cardiogenic shock (CS) is one of the most serious complications of myocardial infarction
(MI) with a high mortality rate. The timely and effective prevention and early suppression of …

Mental health sequelae in survivors of cardiogenic shock complicating myocardial infarction. A population-based cohort study

SM Fernando, D Qureshi, R Talarico, SN Vigod… - Intensive Care …, 2024‏ - Springer
Purpose Cardiogenic shock secondary to acute myocardial infarction (AMI-CS) is associated
with substantial short-and long-term morbidity and mortality. However, there are limited data …

Resource utilization and costs associated with cardiogenic shock complicating myocardial infarction: a population-Based cohort study

S Parlow, SM Fernando, M Pugliese, D Qureshi… - JACC: Advances, 2024‏ - jacc.org
Background Cardiogenic shock due to acute myocardial infarction (AMI-CS) is associated
with significant short-and long-term morbidity and mortality. Despite this, little is known about …

Impact of mechanical circulatory support on outcomes in Takotsubo syndrome complicated by cardiogenic shock: Insights from the RETAKO registry

A Uribarri, R Vazirani, MA Delia, M Tomasino… - International Journal of …, 2025‏ - Elsevier
Background Cardiogenic shock (CS) complicates Takotsubo syndrome (TTS), significantly
affecting patient outcomes. Since avoiding catecholamines, particularly inotropic agents, is …